The company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.

The inventors have created a reverse genetics system for RSV strain B1 of antigenic subgroup B encoding a replication-competent recombinant ... The resulting virus is replication-competent and ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...

Ebola virus, being highly pathogenic for humans and non-human primates and the subject of former weapons programmes, is now one of the most feared pathogens worldwide. In addition, the lack of pre ...

Researchers have taken a major step towards producing a more affordable and lower-risk polio vaccine using virus-like ...

CLEVELAND, Ohio — Eggs are disappearing from store shelves due to shortages caused by the avian flu outbreak, but never fear ...

Indian Institute of Technology Guwahati (IIT Guwahati) is all set to roll out the first recombinant vaccine for Swine Fever virus, an official statement from the institute has confirmed.

FuGU Libraries is now part of Biomedicum Virus Core unit (HelVi-BVC). The BVC facility is equipped with basic cell culture equipment such as laminar hoods, incubators, centrifuges, and microscopes.

The Phase 1 trial is an open label, dose ranging clinical study designed to evaluate Vaxart’s second-generation oral norovirus vaccine constructs head-to-head against its first-generation constructs.

Recombinant innovation is a phrase from the book The Second Machine Age that highlights the way new applications are invented from a combination of existing technologies. For example, the Waze ...

In the outbreak of Ebola virus disease (EVD) in the Democratic Republic of Congo (DRC) between 2018 and 2020, ring ...